In the current study, we built a preoperative breast MR-based deep learning network with automatic tumor detection and MV data augmentation using a cohort of 726 consecutive HER2-positive breast cancer patients receiving different kinds of anti-HER2 treatments. This evidence concerns the gene ERBB2 and breast cancer.